Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2003Seminars in Thrombosis and Hemostasis

Cancer-Related Deep Venous Thrombosis: Clinical Importance, Treatment Challenges, and Management Strategies

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Do low-molecular-weight heparins improve anticoagulation efficacy and safety compared to unfractionated heparin and warfarin in cancer patients with venous thromboembolism?

Population

Cancer patients with venous thromboembolic disease, including deep venous thrombosis and pulmonary embolism

Comparison

Low-molecular-weight heparins (LMWHs) vs Intravenous unfractionated heparin for initial…

Design

Review

Authors

SDSteven R. DeitcherUniversity of Vermont

Discussion

Loading...

Member takes

Implication

Supports LMWH preference over warfarin in cancer VTE; leaves open optimal comparisons with DOACs.

Structured PICO

Do low-molecular-weight heparins improve anticoagulation efficacy and safety compared to unfractionated heparin and warfarin in cancer patients with venous thromboembolism?

P
Population
Cancer patients with venous thromboembolic disease (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE)
I
Intervention
Low-molecular-weight heparins (LMWHs)
C
Comparator
Intravenous unfractionated heparin (UFH) for initial anticoagulation and oral warfarin for chronic anticoagulation
O
Outcome
Efficacy and safety of anticoagulation for VTE management

Low-molecular-weight heparins provide an effective and practical alternative to unfractionated heparin and warfarin for managing venous thromboembolism in cancer patients, addressing specific challenges like heparin resistance and monitoring difficulties.

Cite This Study

Steven R. Deitcher (2003) studied this question.

synapsesocial.com/papers/6a77ddaae539f649abf70a78https://doi.org/10.1055/s-2003-40963

Topics

Anticoagulation in AF
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of Venous Thrombosis in the Cancer Patient2001 · 26 citations
  2. 2Cancer and Venous Thromboembolic Disease: A Review2017 · 254 citations
  3. 3Thrombotic risk in cancer patients: Diagnosis and management of venous thromboembolism2020 · 3 citations
  4. 4What are the pharmacotherapy options for treating venous thromboembolism in cancer patients?2014 · 5 citations
  5. 5Cancer and Thrombosis: Managing the Risks and Approaches to Thromboprophylaxis2006 · 11 citations